These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 19682326)
1. Does Alzheimer's disease begin in the brainstem? Simic G; Stanic G; Mladinov M; Jovanov-Milosevic N; Kostovic I; Hof PR Neuropathol Appl Neurobiol; 2009 Dec; 35(6):532-54. PubMed ID: 19682326 [TBL] [Abstract][Full Text] [Related]
2. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset? Grinberg LT; Rüb U; Ferretti RE; Nitrini R; Farfel JM; Polichiso L; Gierga K; Jacob-Filho W; Heinsen H; Neuropathol Appl Neurobiol; 2009 Aug; 35(4):406-16. PubMed ID: 19508444 [TBL] [Abstract][Full Text] [Related]
3. The Brainstem Tau Cytoskeletal Pathology of Alzheimer's Disease: A Brief Historical Overview and Description of its Anatomical Distribution Pattern, Evolutional Features, Pathogenetic and Clinical Relevance. Rüb U; Stratmann K; Heinsen H; Turco DD; Seidel K; Dunnen Wd; Korf HW Curr Alzheimer Res; 2016; 13(10):1178-97. PubMed ID: 27264543 [TBL] [Abstract][Full Text] [Related]
4. The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Rüb U; Del Tredici K; Schultz C; Thal DR; Braak E; Braak H Neuropathol Appl Neurobiol; 2000 Dec; 26(6):553-67. PubMed ID: 11123722 [TBL] [Abstract][Full Text] [Related]
5. Monoaminergic neuropathology in Alzheimer's disease. Šimić G; Babić Leko M; Wray S; Harrington CR; Delalle I; Jovanov-Milošević N; Bažadona D; Buée L; de Silva R; Di Giovanni G; Wischik CM; Hof PR Prog Neurobiol; 2017 Apr; 151():101-138. PubMed ID: 27084356 [TBL] [Abstract][Full Text] [Related]
6. Neuropathology of Alzheimer's disease: a critical update. Jellinger KA; Bancher C J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917 [TBL] [Abstract][Full Text] [Related]
7. Putative pathological mechanisms of late-life depression and Alzheimer's disease. Hasan SMN; Clarke C; Strand T; Bambico FR Brain Res; 2023 Aug; 1813():148423. PubMed ID: 37244602 [TBL] [Abstract][Full Text] [Related]
8. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657 [TBL] [Abstract][Full Text] [Related]
9. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
10. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease. Wang P; Wang ZY Ageing Res Rev; 2017 May; 35():265-290. PubMed ID: 27829171 [TBL] [Abstract][Full Text] [Related]
11. Neuropathological study of the dorsal raphe nuclei in late-life depression and Alzheimer's disease with and without depression. Hendricksen M; Thomas AJ; Ferrier IN; Ince P; O'Brien JT Am J Psychiatry; 2004 Jun; 161(6):1096-102. PubMed ID: 15169699 [TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical study of the dorsal and median raphe nuclei in patients with Alzheimer's disease prospectively assessed for behavioural changes. Chen CP; Eastwood SL; Hope T; McDonald B; Francis PT; Esiri MM Neuropathol Appl Neurobiol; 2000 Aug; 26(4):347-55. PubMed ID: 10931368 [TBL] [Abstract][Full Text] [Related]
14. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Streit WJ; Braak H; Xue QS; Bechmann I Acta Neuropathol; 2009 Oct; 118(4):475-85. PubMed ID: 19513731 [TBL] [Abstract][Full Text] [Related]
15. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging. Satoh A; Iijima KM Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876 [TBL] [Abstract][Full Text] [Related]
16. Quantifying the accretion of hyperphosphorylated tau in the locus coeruleus and dorsal raphe nucleus: the pathological building blocks of early Alzheimer's disease. Ehrenberg AJ; Nguy AK; Theofilas P; Dunlop S; Suemoto CK; Di Lorenzo Alho AT; Leite RP; Diehl Rodriguez R; Mejia MB; Rüb U; Farfel JM; de Lucena Ferretti-Rebustini RE; Nascimento CF; Nitrini R; Pasquallucci CA; Jacob-Filho W; Miller B; Seeley WW; Heinsen H; Grinberg LT Neuropathol Appl Neurobiol; 2017 Aug; 43(5):393-408. PubMed ID: 28117917 [TBL] [Abstract][Full Text] [Related]
17. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
18. Alzheimer's disease and amyloid: culprit or coincidence? Skaper SD Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834 [TBL] [Abstract][Full Text] [Related]
19. Neuropathology of cognitively normal elderly. Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067 [TBL] [Abstract][Full Text] [Related]
20. Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers. Koychev I; Hofer M; Friedman N J Nucl Med; 2020 Oct; 61(10):1413-1418. PubMed ID: 32764121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]